In silico and in vitro identification of microRNAs that regulate hepatic nuclear factor 4α expression

Drug Metabolism and Disposition

Volumn 40, Issue 4, 2012, Pages 726-733

  Ramamoorthy, Anuradha ^a   Li, Lang ^a   Gaedigk, Andrea ^b   Bradford, L DiAnne ^c   Benson, Eric A ^a   Flockhart, David A ^a   Skaar, Todd C ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

^c MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2D6; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MICRORNA; PURINERGIC RECEPTOR;

3' UNTRANSLATED REGION; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RNA TRANSLATION; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; UPREGULATION; VALIDATION PROCESS;

3' UNTRANSLATED REGIONS; CYTOCHROME P-450 CYP2D6; GENE EXPRESSION REGULATION; GENES, REPORTER; GENOTYPE; HELA CELLS; HEP G2 CELLS; HEPATOCYTE NUCLEAR FACTOR 4; HEPATOCYTES; HUMANS; LUCIFERASES; MICRORNAS; PHARMACEUTICAL PREPARATIONS; PLASMIDS; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 84863391693     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.111.040329     Document Type: Article

References (40)

1. Adams BD, Furneaux H, and White BA (2007) The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-α (ERα) and represses ERα messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 21:1132-1147. (Pubitemid 46984764)
2. Ambros V, Bartel B, Bartel DP, Burge CB, Carrington JC, Chen X, Dreyfuss G, Eddy SR, Griffiths-Jones S, Marshall M, et al. (2003) A uniform system for microRNA annotation. RNA 9:277-279. (Pubitemid 36246165)
3. Bao L, Zhou M, Wu L, Lu L, Goldowitz D, Williams RW, and Cui Y (2007) PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits. Nucleic Acids Res 35:D51-D54. (Pubitemid 46056169)
4. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
5. Borges S, Desta Z, Jin Y, Faouzi A, Robarge JD, Philips S, Philip S, Nguyen A, Stearns V, Hayes D, et al. (2010) Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients. J Clin Pharmacol 50:450-458.
6. Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, Novik KL, Kelemen L, Ogata S, Pharoah PD, et al. (2004) Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 96:936-945. (Pubitemid 38868140)
7. Duursma AM, Kedde M, Schrier M, le Sage C, and Agami R (2008) miR-148 targets human DNMT3b protein coding region. RNA 14:872-877. (Pubitemid 351574909)
8. Gaedigk A, Simon SD, Pearce RE, Bradford LD, Kennedy MJ, and Leeder JS (2008) The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype. Clin Pharmacol Ther 83:234-242.
9. Georges M, Clop A, Marcq F, Takeda H, Pirottin D, Hiard S, Tordoir X, Caiment F, Meish F, Bibé B, et al. (2006) Polymorphic microRNA-target interactions: a novel source of phenotypic variation. Cold Spring Harb Symp Quant Biol 71:343-350.
10. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, and Enright AJ (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34:D140-D144.
11. Gruber AR, Lorenz R, Bernhart SH, Neuböck R, and Hofacker IL (2008) The Vienna RNA websuite. Nucleic Acids Res 36:W70-W74.
12. Harries LW, Locke JM, Shields B, Hanley NA, Hanley KP, Steele A, Njølstad PR, Ellard S, and Hattersley AT (2008) The diabetic phenotype in HNF4A mutation carriers is moderated by the expression of HNF4A isoforms from the P1 promoter during fetal development. Diabetes 57:1745-1752.
13. Hatzis P and Talianidis I (2001) Regulatory mechanisms controlling human hepatocyte nuclear factor 4α gene expression. Mol Cell Biol 21:7320-7330. (Pubitemid 32953485)
14. Hayhurst GP, Lee YH, Lambert G, Ward JM, and Gonzalez FJ (2001) Hepatocyte nuclear factor 4α (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 21:1393-1403. (Pubitemid 32114986)
15. Ihara A, Yamagata K, Nammo T, Miura A, Yuan M, Tanaka T, Sladek FM, Matsuzawa Y, Miyagawa J, and Shimomura I (2005) Functional characterization of the HNF4α isoform (HNF4α8) expressed in pancreatic β-cells. Biochem Biophys Res Commun 329:984-990. (Pubitemid 40341373)
16. Ingelman-Sundberg M, Sim SC, Gomez A, and Rodriguez-Antona C (2007) Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther 116:496-526. (Pubitemid 350116943)
17. Iwazaki N, Kobayashi K, Morimoto K, Hirano M, Kawashima S, Furihata T, and Chiba K (2008) Involvement of hepatocyte nuclear factor 4α in transcriptional regulation of the human pregnane X receptor gene in the human liver. Drug Metab Pharmacokinet 23:59-66.
18. John B, Enright AJ, Aravin A, Tuschl T, Sander C, and Marks DS (2004) Human microRNA targets. PLoS Biol 2:e363.
19. Kamiyama Y, Matsubara T, Yoshinari K, Nagata K, Kamimura H, and Yamazoe Y (2007) Role of human hepatocyte nuclear factor 4α in the expression of drug-metabolizing enzymes and transporters in human hepatocytes assessed by use of small interfering RNA. Drug Metab Pharmacokinet 22:287-298.
20. Kertesz M, Iovino N, Unnerstall U, Gaul U, and Segal E (2007) The role of site accessibility in microRNA target recognition. Nat Genet 39:1278-1284. (Pubitemid 47482690)
21. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37:495-500. (Pubitemid 40617277)
22. Kreuzer KA, Lass U, Bohn A, Landt O, and Schmidt CA (1999) LightCycler technology for the quantitation of bcr/abl fusion transcripts. Cancer Res 59:3171-3174. (Pubitemid 29316018)
23. Lewis BP, Burge CB, and Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20. (Pubitemid 40094598)
24. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, and Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115:787-798. (Pubitemid 38058492)
25. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, and Rigoutsos I (2006) A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes. Cell 126:1203-1217. (Pubitemid 44380294)
26. Mishra PJ, Humeniuk R, Mishra PJ, Longo-Sorbello GS, Banerjee D, and Bertino JR (2007) A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci USA 104:13513-13518. (Pubitemid 47293976)
27. Olsen PH and Ambros V (1999) The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol 216:671-680. (Pubitemid 30013313)
28. Ørom UA, Nielsen FC, and Lund AH (2008) MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 30:460-471. (Pubitemid 351672378)
29. Pan YZ, Gao W, and Yu AM (2009) MicroRNAs regulate CYP3A4 expression via direct and indirect targeting. Drug Metab Dispos 37:2112-2117.
30. Place RF, Li LC, Pookot D, Noonan EJ, and Dahiya R (2008) MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA 105:1608-1613. (Pubitemid 351346562)
31. Ramamoorthy A and Skaar TC (2011) In silico identification of microRNAs predicted to regulate the drug metabolizing cytochrome P450 genes. Drug Metabolism Letters 5:126-131.
32. Stoffel M and Duncan SA (1997) The maturity-onset diabetes of the young (MODY1) transcription factor HNF4α regulates expression of genes required for glucose transport and metabolism. Proc Natl Acad Sci USA 94:13209-13214. (Pubitemid 27518501)
33. Takagi S, Nakajima M, Kida K, Yamaura Y, Fukami T, and Yokoi T (2010) MicroRNAs regulate human hepatocyte nuclear factor 4α, modulating the expression of metabolic enzymes and cell cycle. J Biol Chem 285:4415-4422.
34. Takagi S, Nakajima M, Mohri T, and Yokoi T (2008) Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4. J Biol Chem 283:9674-9680.
35. To KK, Zhan Z, Litman T, and Bates SE (2008) Regulation of ABCG2 expression at the 3′untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line. Mol Cell Biol 28:5147-5161.
36. Tsuchiya Y, Nakajima M, Takagi S, Taniya T, and Yokoi T (2006) MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res 66:9090-9098. (Pubitemid 44521128)
37. Wang J, Pitarque M, and Ingelman-Sundberg M (2006) 3′-UTR polymorphism in the human CYP2A6 gene affects mRNA stability and enzyme expression. Biochem Biophys Res Commun 340:491-497. (Pubitemid 43021775)
38. Wortham M, Czerwinski M, He L, Parkinson A, and Wan YJ (2007) Expression of constitutive androstane receptor, hepatic nuclear factor 4α, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver. Drug Metab Dispos 35:1700-1710. (Pubitemid 47296067)
39. Xie X, Lu J, Kulbokas EJ, Golub TR, Mootha V, Lindblad-Toh K, Lander ES, and Kellis M (2005) Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 434:338-345. (Pubitemid 40469170)
40. Yekta S, Shih IH, and Bartel DP (2004) MicroRNA-directed cleavage of HOXB8 mRNA. Science 304:594-596. (Pubitemid 38541919)